Chloropretadalafil
Chloropretadalafil (Compound 31) is a key intermediate that can be used to synthesize Tadalafil (HY-90009A) derivatives[1].
Product Specifications
CAS Number
[171489-59-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Others
Purity
99.43
Smiles
ClCC(N1[C@H](C2=CC=C(OCO3)C3=C2)C4=C(C[C@@H]1C(OC)=O)C5=CC=CC=C5N4)=O
Molecular Formula
C22H19ClN2O5
Molecular Weight
426.85
Precautions
H302, H315, H319, H335
References & Citations
[1]Sánchez-Arias JA, et al. Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease. ACS Chem Neurosci. 2017 Mar 15;8 (3) :638-661.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W098292/
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
